U.S. Capital Wealth Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $241K | Buy |
459
+45
| +11% | +$23.6K | 0.01% | 780 |
|
|
2025
Q1 | $263K | Sell |
414
-15
| -3% | -$9.52K | 0.01% | 734 |
|
|
2024
Q4 | $306K | Sell |
429
-1,746
| -80% | -$1.24M | 0.01% | 678 |
|
|
2024
Q3 | $2.29M | Hold |
2,175
| – | – | 0.08% | 229 |
|
|
2024
Q2 | $2.29M | Buy |
2,175
+67
| +3% | +$70.4K | 0.09% | 218 |
|
|
2024
Q1 | $2.03M | Buy |
2,108
+820
| +64% | +$789K | 0.08% | 227 |
|
|
2023
Q4 | $1.13M | Buy |
1,288
+245
| +23% | +$215K | 0.04% | 319 |
|
|
2023
Q3 | $858K | Buy |
1,043
+1
| +0.1% | +$823 | 0.04% | 340 |
|
|
2023
Q2 | $749K | Buy |
1,042
+180
| +21% | +$129K | 0.04% | 373 |
|
|
2023
Q1 | $708K | Buy |
862
+1
| +0.1% | +$822 | 0.03% | 369 |
|
|
2022
Q4 | $621K | Buy |
+861
| New | +$621K | 0.03% | 417 |
|